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RNA Logic Gates
Modular and Versatile Trans-Encoded Genetic Switches
Avishek Paul, Eliza M. Warszawik, Mark Loznik, Arnold J. Boersma, and Andreas Herrmann*
Abstract: Current bacterial RNA switches suffer from lack of
versatile inputs and are difficult to engineer. We present
versatile and modular RNA switches that are trans-encoded
and based on tRNA-mimicking structures (TMSs). These
switches provide a high degree of freedom for reengineering
and can thus be designed to accept a wide range of inputs,
including RNA, small molecules, and proteins. This powerful
approach enables control of the translation of protein expres-
sion from plasmid and genome DNA.
Synthetic non-coding RNAs with simple and limited con-
formational states have been deployed to build RNA switches
to control bacterial translation.[1–3] Many RNA switches suffer
from low dynamic response and lack of versatility with respect
to input signals that can be processed. Nonetheless, great
progress involving sophisticated RNA switches has been
made.[4–11] These RNA switches act in cis on the target mRNA
(i.e., act on the same molecule, while trans-acting switches act
on a different molecule) to achieve fast and efficient
functionality with high on/off-ratio. The “toehold switch” is
a prime example of such an RNA device with strong dynamic
response, orthogonality, and possibility for logic-gate oper-
ations.[12] There are also ligand-dependent riboswitches that
are cis-acting with regard to the target mRNA.[13] The
incorporation of cis-encoded switches at the leader mRNA
may however interfere with folding of downstream mRNA[14]
and will require genetic modification upstream of the target
gene. The importance of the leader mRNA sequence has been
well documented for 5’-UTR-encoded regulators of patho-
genic bacteria.[15] Trans-encoded switches would not present
sequence constraints on the target mRNA. For example,
a trans-encoded switch based on the looped antisense
oligonucleotide (LASO) can repress a downstream gene in
presence of an input RNA[16] but does not accept other signals
such as small molecules or proteins. Hence, limited by their
design, current artificial switches lack modularity with respect
to input signals.
To overcome these limitations, we present trans-encoded
genetic switches based on a tRNA-mimicking structure
(TMS; Figure 1). Bacterial tRNA is stable to RNase and
allows stable expression of RNA constructs in the cells.[17,18]
Since the TMS switch is trans-encoded, it does not disturb the
secondary structure of the target mRNA. The concept of TMS
is based on metazoan mitochondrial tRNAs that display
diverse sequences and structures.[19] We hypothesized that
sequence variation of different arms of the tRNA structure
would allow easy incorporation of modules with different
functions into the switch.
To achieve tight control over gene expression, we
designed the switch to bind both flanking sites of the
ribosome binding site (RBS) of the target mRNA, without
disturbing the RBS and the start codon, to block ribosome
entry and subsequent translation.
We incorporated a repressor domain into the anticodon
loop of the bacterial tRNAlys that binds flanking sites of the
RBS (Figure 1 and Figure S1 in the Supporting Information).
To reverse the effect of the repressor, we designed an anti-
repressor RNA that binds the TMS through loop–loop
interactions and pulls off the repressor domain from the
mRNA, thereby liberating the RBS for binding to the
ribosome. To provide initiation sites for the binding between
the TMS switch and the anti-repressor RNA, we incorporated
two 9 nt initial binding elements (IBEs), one at each end of
the repressor domain of the TMS switch. To make the design
process simple, we consider the IBEs as a part of the repressor
domain. We name this switch d-TMSIBE.
Figure 1. Concept to switch protein translation: Modification of the
anticodon loop of a tRNA (1) blocks ribosome binding (2), which can
be reversed by an anti-repressor RNA (3), thereby allowing GFP
expression (4). A and B denote the two subdomains in the repressor
domain. The initial binding element (IBE) hybridizes with the anti-
repressor RNA.
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For characterization of the switch, we used a two-plasmid
system[11] and co-expressed the anticodon-modified TMS
switch and a GFP reporter from the two separate plasmids
(Figure S2) in Escherichia coli BL21(DE3) cells. We varied
the length of regions A and B in the repressor domain and
tested their ability to repress GFP by flow cytometry. Three
out of eight d-TMSIBE switches showed effective GFP
repression (Figure S3). These three switches contain the
longest A and B domains (> 12 nts), likely because the 8 nt
transmitter domain needs to dehybridize for the switch to
bind the mRNA. We selected the d-TMSIBE switch with the
longest regions of A = 10 nt and B = 8 nt to obtain the best
binding characteristics. We determined the minimum length
of the stem in the repressor domain and the stem that
connects the repressor domain with the tRNA structure
(Figure S4). The need for a minimum stem length is likely due
to the stability provided by a tRNA structure in an RNAse
environment (see below). The d-TMSIBE switch maintains its
functionality even with a variable loop of 1 nt length.
Useful switches need to be stable to degradation by
RNAses. For example, a trans-encoded bacterial switch that
binds the protein Hfq is stable to RNAse.[20] To investigate the
stability of the d-TMSIBE switch in RNase environment, we
compared repression of GFP expression by the d-TMSIBE
switch with an RNA oligomer containing only the repressor
sequence (Figure S5). The d-TMSIBE switch repressed GFP
expression 21-fold more effectively than the RNA oligomer,
thus demonstrating that the d-TMSIBE provides stability to
the RNA-based switch in an environment where RNAse is
present.
To reverse the repression of the GFP gene by the d-
TMSIBE switch, we simultaneously expressed an anti-
repressor RNA from the d-TMSIBE switch plasmid (Fig-
ure S6). We again used a TMS structure for the anti-repressor
RNA to provide stability. Cells expressing both the anti-
repressor RNA and the d-TMSIBE switch showed almost the
same GFP intensity as in absence of both interacting TMSs
(Figure 2a). The ON/OFF ratio of the d-TMSIBE switch was
around 200-fold.
Next, we determined the orthogonality of six d-TMSIBE
switches and their cognate anti-repressor RNAs (Figure 2b).
We varied the repressor domain sequence of the d-TMSIBE
switches while retaining the ability to bind to the target
mRNA. Combination of each of the d-TMSIBE switches with
each of the anti-repressor RNAs resulted in fold changes in
GFP expression varying between 180 and 210 for each
cognate pair and less than 2 for each non-cognate pair. Hence,
our system is highly selective concerning the d-TMSIBE switch
and cognate anti-repressor RNA.
To increase the versatility of input signals, we inserted an
aptamer as an additional module into the d-loop of the TMS
switch. The d-loop determines the tertiary structure of tRNA.
Previously, an aptamer was coupled to a self-cleaving
ribozyme in order to create a ligand-dependent ribo-
switch,[21–23] which was stabilized at its base-paired stem by
binding its ligand. In our case, we hypothesize that such
stabilization of a base-paired stem in the d-loop would
provide the energy to regain the tRNA structure with
concomitant release of the TMS from the mRNA. The well-
studied hybridized structure of the neomycin B (NeoB)
aptamer shows that it has increased stability upon neo-
mycin B binding.[24, 25] To verify the TMS switch activity
against a small molecule, we selected azide-modified neo-
mycin B[26] as input.
We replaced the d-loop of the TMS switch with a neo-
mycin B aptamer[27] sequence (NeoB-TMS-IBE, Figure 3 a and
Figure S7). The NeoB aptamer exhibits a low micromolar
binding affinity to azide-modified neomycin B (Figure S8).
Modifying the 2-deoxystreptamine ring of neomycin B with
an azide reduces its antibacterial activity (Figure S9 and S10)
and allows its use as a non-bioactive input signal at lower
concentrations. We removed the IBE elements at the
repressor domain. With the incorporation of the neomycin B
aptamer, the TMS switch is now comprised of a sensor (that
recognizes a small-molecule input signal), an actuator (that
controls the output signal), and a transmitter (that channels
the signal from the sensor to the actuator; see Figure 3a top
left). This RNA architecture responds in a concentration-
dependent manner to azide-modified neomycin B as input
(Figure 3b), thereby demonstrating that the NeoB-TMS-IBE
structure can function as an analogue genetic switch against
a small-molecule input signal.[28]
In addition to small molecules, the switch accepts GFP as
an input signal with a GFP aptamer[29] integrated into the d-
loop of the TMS (GFP-TMS-IBE, Figure 3a). We used
mCherry as an output signal, controlled under an arabinose
promoter, while inducing GFP with anhydrotetracycline. The
behavior of the GFP-TMS-IBE switch against a gradient GFP
input signal was similar as that of the NeoB-TMS-IBE switch
with the small-molecule input signal (Figure 3c). To demon-
strate that the RNA switch can function as an OR logic gate in
live cells, we programmed this gate by incorporating
a repressor domain and the neomycin B aptamer together in
a single TMS switch (NeoB-TMS+IBE, Figure 4). The logic
gate gave the expected output signal: Cells only express GFP
in the presence of the anti-repressor RNA or azide-modified
neomycin B (Figure 4).
To assess whether the ligand-mediated stabilization of the
TMS switch solely depends on the interaction with the
corresponding aptamer, we replaced the neomycin B aptamer
Figure 2. a) GFP fluorescence measured by flow cytometry for the
anticodon-modified TMS switch in the ON and OFF states (presence
and absence of the anti-repressor RNA). Negative control is without
GFP induction, positive control is with GFP induction in the absence
of TMS. b) Orthogonality of six different d-TMSIBE switches and their
cognate anti-repressor RNAs. The GFP fold change is the GFP




2 www.angewandte.de  2020 Die Autoren. Verçffentlicht von Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Angew. Chem. 2020, 132, 1 – 6
 
These are not the final page numbers!
of NeoB-TMS-IBE with a kanamycin B aptamer[30] (KanB-
TMS-IBE). Azide-modified neomycin B has a very low binding
affinity for the kanamycin B aptamer (Figure S11). Indeed,
due to the lower affinity of the kanamycin B aptamer for
azide-modified neomycin B, KanB-TMS-IBE is unable to
control gene expression with azide-modified neomycin B
(Figure S12). Hence, the ligand-mediated structural changes
in the TMS switch depend on the affinity of the ligand for the
aptamer component of the switch.
We next asked whether the TMS switches can be deployed
to target the bacterial genome. A d-TMSIBE switch was
designed to target the T7 RNA polymerase gene present in
the genome of the E. coli BL21(DE3) cells (Figure 5a),
binding from 30 to 1 bases upstream of the start codon in
the corresponding mRNA. The d-TMSIBE switch is under
control of the strong constitutive lpp promoter. To induce T7
polymerase expression, we added 0.1 mm isopropyl b-d-1-
thiogalactopyranoside (IPTG). As a marker, GFP expression
from a plasmid controlled by a T7 promoter should be
reduced when the d-TMSIBE switch represses T7 RNA
polymerase translation. Indeed, we observed that the pres-
ence of the d-TMSIBE switch reduced GFP fluorescence
(Figure 5b). Importantly, binding cognate antirepressor RNA
to the d-TMSIBE switch showed full GFP fluorescence, thus
showing that genomic expression can also be switched
(Figure S13). GFP expression is only marginally reduced
further when a second d-TMSIBE switch that targets the +11
to +30 bases upstream of the start codon of the T7
polymerase mRNA is employed simultaneously with the
first d-TMSIBE, thus indicating the excellent performance of
the switches.
Figure 3. a) Controlling gene expression by the NeoB-TMS-IBE and GFP-
TMS-IBE switches (1). Binding of the switches prevents ribosome
binding (2), which is reversed by binding of the corresponding
aptamer ligand (3). The GFP-TMS-IBE switch controls mCherry expres-
sion. b) Titration of azide-conjugated neomycin B leads to increased
GFP production. c) Inducing GFP expression with anhydrotetracyclin
leads to increasing mCherry fluorescence.
Figure 4. Design of an OR logic gate with the NeoB-TMSIBE switch,
responding to its cognate anti-represssor RNA and azide-modified
neomycin B (100 mm). All experiments were performed in triplicate.
Median fluorescence is reported. AR = Anti-repressor RNA; NeoB
azide= azide-modified neomycin B.
Figure 5. a) Switching genomic gene expression. The d-TMSIBE switch
prevents expression of T7 RNA polymerase, by binding the 30 to 1
bases of the T7 polymerase gene. GFP expression is recovered with
the cognate anti repressor RNA. b) Corresponding flow cytometry data
showing repression of expression with d-TMSIBE (OFF TMS switch),
activation with the anti-repressor RNA (ON TMS switch), and controls
as in Figure 2, but under a T7 promoter. c) Box plot showing that
inhibiting a native E. coli gene ftsZ with two d-TMSIBE switches leads to
filamentous growth compared to cells without any d-TMSIBE switch.
Coexpression of the cognate anti-repressor RNAs leads to restoration
of cell sizes similar to d-TMSIBE-free cells. n = 500 cells. d) Correspond-
ing confocal microscopy brightfield images. Scale bar = 7.6 mm. All
experiments were performed in triplicate.
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A key advantage of a trans-encoded switch is that it allows
genes in the genome to be targeted without sequence
alteration of the genome. To demonstrate inhibition of
native gene expression, we targeted the d-TMSIBE switch
versus the ftsZ gene in the genome, which encodes for the
FtsZ protein (Figure 5d). FtsZ is an essential protein for cell
division that forms a contractile ring structure (Z ring) at the
future cell-division site.[31] One of the functions of the FtsZ
ring is to recruit other cell division proteins to the septum to
produce a new cell wall between the dividing cells.[32]
Inhibiting the FtsZ production would hamper the cell-division
process, leading to filamentous growth of E. coli cells.[33,34]
Unlike the T7 polymerase gene in the bacterial genome, the
ftsZ gene is controlled by a constitutive promoter. Therefore,
we decided to express two d-TMSIBE switches simultaneously
to target the ftsZ gene in order to achieve tight control of FtsZ
expression. One d-TMSIBE switch binds to the 19 to +11
nucleotides region and the other binds to the +32 to +61
nucleotides region from the start codon of the ftsZ gene.
Transcription of both d-TMSIBE switches led to filamentous
cells and a larger spread of cell lengths in comparison with
cells without the switches (Figure 5c; Figure S14). Both
switches accept inputs from their respective cognate antire-
pressor RNAs, also expressed simultaneously, giving cells
with the same average length and distribution as untreated
cells. Hence, we can repress translation of mRNAs tran-
scribed from both plasmid and genome without alteration of
the target mRNA sequence, and subsequently turn on gene
expression with input signals.
In summary, we present powerful new RNA-based
switches that provide unparalleled versatility in controlling
bacterial gene expression. Unlike other cis-acting genetic
switches, the TMS switches do not pose sequence constrains
on the target mRNA. By designing RNA switches that accept
versatile inputs (RNA, small molecules, and proteins), we
have been able to compensate for the low chemical diversity
of input signals of the current RNA switches compared to
their protein counterparts.[35] A remarkable feature of the
TMS switches is that the simple replacement of modules
enables sensing of new input signals, and even addition of
a second sensing module does not compromise performance
of the RNA device as realized by the logic-gate design. The
switches that we developed here display a strong dynamic
range, likely due to the stability of the TMS structure tuned by
the unique design of the repressor domain. With their unique
combination of signal processing of desired inputs and
targeting any desired mRNA, the TMS switches will play an
essential role in novel genetic circuitry to allow advanced
information processing in synthetic biology.
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Modular and Versatile Trans-Encoded
Genetic Switches
Switch-hitter : A bacterial genetic switch
that accepts RNAs, small molecules, and
proteins as inputs was developed based
on a tRNA-mimicking structure. The
switch is trans-encoded, which makes
manipulation of the target mRNA redun-
dant. It is stable to RNase, shows
a strong dynamic response, and exhibits
a high level of orthogonality.
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